FDA says no to AZ’s Fasenra for nasal polyp indication
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
KEYPOINTS: Spirofy is India’s first pneumotach-based portable wireless Spirometer for the diagnosis of COPD and asthma. The company intends with this launch…
Abstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…
Keypoints UPL is the largest manufacturer and distributor of biosolutions worldwide. On 28 June 2021 UPL Ltd, a world leader in sustainable…
Keypoints Hansen is joining forces with global agricultural solutions provider UPL in a unique partnership to strengthen the existing portfolio of microbial…